These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of 6-hydroxydopamine on contractions produced by sympathomimetic amines in the human isolated vas deferens. Ratnasooriya WD; Wadsworth RM J Pharm Pharmacol; 1979 May; 31(5):348-50. PubMed ID: 37313 [No Abstract] [Full Text] [Related]
6. Action of various sympathomimetic amines on the isolated stripped vas deferens of the guinea-pig. Nedergaard OA; Westermann E Br J Pharmacol; 1968 Nov; 34(3):475-83. PubMed ID: 4302376 [TBL] [Abstract][Full Text] [Related]
7. Responses of the isolated sympathetic nerve-ductus deferens preparation of the guinea-pig. 1961. Huković S Br J Pharmacol; 1997 Feb; 120(4 Suppl):195-201; discussion 192-4. PubMed ID: 9142406 [TBL] [Abstract][Full Text] [Related]
8. The sympathomimetic activity of fenfluramine hydrochloride on rat vas deferens. Mottram DR; Wadhwani D Br J Pharmacol; 1977 Apr; 59(4):615-20. PubMed ID: 870124 [TBL] [Abstract][Full Text] [Related]
9. Sympathomimetic activity of mazindol on rat anococcygeus muscle and vas deferens. Zarrindast MR Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):258-63. PubMed ID: 6712359 [TBL] [Abstract][Full Text] [Related]
10. Metiamide potentiates the stimulant actions of sympathomimetic amines "in vitro". Tayo FM Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):211-8. PubMed ID: 6773485 [TBL] [Abstract][Full Text] [Related]
11. Sympathomimetic amine-induced release of norepinephrine-3H from different intraneuronal storage compartments. Takimoto GS; Amiri BA; Cho AK Pharmacology; 1981; 23(6):310-25. PubMed ID: 7312941 [TBL] [Abstract][Full Text] [Related]
12. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens. Laporte J; Jané F; Valdecasas FG J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539 [No Abstract] [Full Text] [Related]
13. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs. Ambache N; Dunk LP; Verney J; Zar MA J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926 [TBL] [Abstract][Full Text] [Related]
14. Effect of reserpine, phenoxybenzamine and cocaine on neuromuscular transmission in the vas deferens of the guinea pig. Wakade AR; Krusz J J Pharmacol Exp Ther; 1972 May; 181(2):310-7. PubMed ID: 4337865 [No Abstract] [Full Text] [Related]
15. Calcium-independent release of 3H-norepinephrine from reserpine-pretreated guinea-pig vas deferens and seminal vesicle. Wakade AR; Kirpekar SM J Pharmacol Exp Ther; 1974 Sep; 190(3):451-8. PubMed ID: 4412280 [No Abstract] [Full Text] [Related]
16. Analysis of the effects of dopamine and noradrenaline in relation to the proposed postsynaptic dopamine receptor in rat vas deferens. Langeloh A; Jurkiewicz A Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):202-9. PubMed ID: 7063046 [No Abstract] [Full Text] [Related]
17. Studies on the modes of action of dicyclohexylamine and related amines with a potentiating effect on noradrenaline responses in the rat vas deferens. Mottram DR; Hickman JA Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):50-8. PubMed ID: 543749 [TBL] [Abstract][Full Text] [Related]
18. Steric aspects of adrenergic drugs. XX. Accumulation of (-)- and (+)-norepinephrine- 14 C by peripheral tissues of the rat. Krell RD; Patil PN J Pharmacol Exp Ther; 1972 Aug; 182(2):273-83. PubMed ID: 5048364 [No Abstract] [Full Text] [Related]
19. A study of the sympathomimetic action of guanethidine on the isolated anococcygeus muscle of the rat. Foster RW; Shah DS; Small RC Br J Pharmacol; 1978 Feb; 62(2):307-13. PubMed ID: 623942 [TBL] [Abstract][Full Text] [Related]
20. Presynaptic inhibition of neurotransmission in rat vas deferens by 2-(p-methoxyphenyl) adenosine, ethyl adenosine-5'-carboxylate and N-cyclopropyl adenosine-5'-carboxamide. Paton DM J Pharm Pharmacol; 1980 Feb; 32(2):133-5. PubMed ID: 6103035 [No Abstract] [Full Text] [Related] [Next] [New Search]